Insider filing
Traded Nov 2 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ESLA · NASDAQ · Biological Products, (No Diagnostic Substances)
Estrella Immunopharma (ESLA) · oqro.io/stocks/ESLA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$0.38−0.134 (−26.07%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
Including 5 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Nov 2 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Aug 25, 2026 · largest single transaction ~$82K
Aug 25, 2026100K · @ $0.815
DetailsOfficial recordTraded Aug 18, 2026 · largest single transaction ~$82K
Aug 18, 2026100K · @ $0.815
DetailsOfficial recordAug 18, 2026100K
Traded Sep 11 – Oct 7, 2025 · largest single transaction ~$1.3K
Sep 22, 2025~$1.2K · 1,000 sh @ $1.16
DetailsOfficial recordAug 25, 2026100K
Oct 7, 2025~$1.3K · 1,000 sh @ $1.33
DetailsOfficial recordSep 11, 2025~$104 · 100 sh @ $1.04
DetailsOfficial recordNo earnings release (8-K Item 2.02) is on file for ESLA, so its insider trades cannot be placed against one.